
Sign up to save your podcasts
Or


Will gene therapy companies produce healthy returns for investors? Ron Gross explains why he’s investing in gene therapy companies and shares his big question for the year ahead.
By The Motley Fool4.7
16041,604 ratings
Will gene therapy companies produce healthy returns for investors? Ron Gross explains why he’s investing in gene therapy companies and shares his big question for the year ahead.

3,217 Listeners

1,482 Listeners

808 Listeners

944 Listeners

521 Listeners

1,170 Listeners

2,201 Listeners

825 Listeners

1,422 Listeners

1,038 Listeners

9,715 Listeners

195 Listeners

833 Listeners

84 Listeners

584 Listeners

1,049 Listeners

56 Listeners